Viewing Study NCT06869551


Ignite Creation Date: 2025-12-24 @ 11:53 PM
Ignite Modification Date: 2026-01-02 @ 8:20 AM
Study NCT ID: NCT06869551
Status: RECRUITING
Last Update Posted: 2025-12-17
First Post: 2025-03-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module